Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch article

Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric italian experience

Nicola Avenia1* email, Alessandro Sanguinetti1* email, Roberto Cirocchi2* email, Giovanni Docimo3* email, Mark Ragusa4* email, Roberto Ruggiero3* email, Eugenio Procaccini3* email, Carlo Boselli2* email, Fabio D'Ajello1* email, Francesco Barberini2* email, Domenico Parmeggiani3* email, Lodovico Rosato5* email, Francesco Sciannameo2* email, Giorgio De Toma6* email and Giuseppe Noya2* email

Endocrine Surgical Unit, University of Perugia, Italy

General Surgical Unit, University of Perugia, Italy

General Surgical Unit, Second University of Naples, Italy

Thoracic Surgical Unit, University of Perugia, Italy

Endocrine Surgical Unit, ASL9-H of Ivrea (Torino), Italy

Department of Surgery "P. Valdoni", University of Rome, Italy

author email corresponding author email* Contributed equally

Annals of Surgical Innovation and Research 2009, 3:10doi:10.1186/1750-1164-3-10

Published: 5 August 2009

Abstract

Post-operatory wound infections are a very uncommon finding after thyroidectomy. For these reasons international guidelines do not routinely recommend systemic antibiotic prophylaxis.

The benefits of this antibiotic prophylaxis is not supported by clinical evidence in the literature. We have conducted a multicentric randomized double-blind trial on 500 patients who had undergone thyroidectomy for goitre or thyroid carcinoma. The 500 patients enrolled in the study (mean age 47 years) were randomized in two subgroups of 250 patients. 250 patients were treated with standard antibiotic prophylaxis with sulbactam/ampicillin 1 fl (3 gr.) 30 min before surgery. No antibiotic prophylaxis was instituted in the remainder 250 patients. Our RCT showed that prophylactic antibiotic treatment is not beneficial in patients younger than eighty years old, with no concomitant metabolic, infective and hematologic disease, with no cardiac valvulopathies, not under steroidal or immunosuppressive treatment, and not severely obese. Our study should be regarded only as a preliminary RCT, and should be followed by a study in which a larger number of patients should be enrolled so that statistically significant data can be obtained.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.